Search

Just four out of ten Portuguese firms were actively investing in innovation between 2002 and 2004, according to a new report.

Pharmaceutical companies need to replenish their portfolios. But are biologics the way to go? Part 2 of Nuala Moran's report from Düsseldorf.

Booz Allen Hamilton’s second annual global innovation survey promises to continue last year's debate on the link between R&D spending and corporate performance.

The new system developed over the past six years by Chalmers University of Technology has notched up its first exit.

A French start-up is joining forces with Microsoft to enlarge its innovative multiplatform datas and services engines to .Net environment.

The head of Microsoft’s Cambridge lab outlines the strategy: to scout the science world for new software markets.

Traditional innovation has been about creating something new that an individual can pay for. That’s no longer enough, says Mats Williander.

This time it is a major drugs company that is setting up its fume cupboards in China.

Do you qualify for R&D Tax Credits? The Treasury offers advice for companies that spend on R&D in the UK.

On October 22, Japan’s Supreme Court struck a blow for employees of major corporations, who make valuable inventions.

The UK’s Technology Strategy Board is to become independent of government, taking over the programme currently run from within the Department of Trade and Industry.

Cambridge Enterprise’s new director vows flexibility as she enforces a controversial new campus policy on intellectual property.

Once considered synonymous with British manufacturing prowess, ICI has announced a major investment in R&D in China.

Innovation has become one of the most important elements in contemporary policymaking - but it's frequently found in unlikely places, says a new report.

Britain is making a new bid to attract global business looking to locate R&D activities overseas and foreign universities seeking overseas collaborations.